Cite
HARVARD Citation
Brunton, S. et al. (2019). Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i). Current medical research and opinion. pp. 1607-1614. [Online].